ArticleJournal of imaging informatics in medicine2026
Robust Histopathology Subtyping via Perturbation Fidelity in Deep Classifier.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning for invasive lung adenocarcinoma subtyping remains vulnerable to real-world imaging perturbations. We present a margin consistency framework evaluating 203,226 patches from 143 whole-slide images across five adenocarcinoma subtypes from the BMIRDS-LUAD dataset. Our approach integrates attention-weighted aggregation with margin-aware training, achieving strong feature-logit space alignment with Kendall correlations of 0.88 during training and 0.64 during validation. To address feature over-clustering from contrastive regularization, we introduce Perturbation Fidelity scoring that applies structured perturbations through Bayesian-optimized parameters. Vision Transformer-Large achieves 95.20±4.65 percent accuracy, representing 40% error reduction from 92.00±5.36% baseline. ResNet101 with attention mechanism reaches 95.89±5.37% from 91.73±9.23% baseline, a 50% error reduction. All five subtypes exceed 0.99 area under receiver operating characteristic curves. Cross-institutional validation on WSSS4LUAD achieves 80.1% accuracy with ResNet50 with attention mechanism, demonstrating method robustness despite approximately 15-20% performance degradation from domain shift, indicating opportunities for future domain adaptation research.
Indexed as
Identifiers
41840135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.